Arterra Bioscience S.p.A. (BIT: ARBS)
Italy
· Delayed Price · Currency is EUR 1.930
-0.090 (-4.46%)
Nov 15, 2024, 5:29 PM CET
Arterra Bioscience Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | - | 1.08 | 1.41 | 1.11 | 1.11 | 0.86 | Upgrade
|
| Depreciation & Amortization | - | 0.53 | 0.53 | 0.49 | 0.4 | 0.3 | Upgrade
|
| Other Operating Activities | - | -0.34 | 0.14 | -0.03 | 0.02 | -0.13 | Upgrade
|
| Change in Accounts Receivable | - | -0.18 | 0.29 | -0.76 | 0.07 | 0.22 | Upgrade
|
| Change in Inventory | - | -0.2 | -0.67 | 0.08 | -0.14 | -0.16 | Upgrade
|
| Change in Accounts Payable | - | 0.06 | -0.06 | 0.06 | -0.31 | 0.24 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.07 | -0.25 | 0.44 | -0.67 | 0.41 | Upgrade
|
| Operating Cash Flow | - | 1.03 | 1.4 | 1.4 | 0.48 | 1.73 | Upgrade
|
| Operating Cash Flow Growth | - | -26.48% | -0.11% | 191.10% | -72.34% | 82.18% | Upgrade
|
| Capital Expenditures | - | -0.07 | -0.09 | -0.54 | -0.34 | -0.84 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.02 | 0.04 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.02 | -0 | -0.07 | -0.04 | -0.76 | Upgrade
|
| Investment in Securities | - | -0.77 | -1.63 | -0.5 | - | 0.01 | Upgrade
|
| Investing Cash Flow | - | -0.84 | -1.69 | -1.11 | -0.38 | -1.6 | Upgrade
|
| Short-Term Debt Issued | - | 0.1 | - | 0 | 0 | 0.02 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.4 | Upgrade
|
| Total Debt Issued | - | 0.1 | - | 0 | 0 | 0.42 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.04 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.2 | -0.08 | -0.2 | -0.19 | -0.31 | Upgrade
|
| Total Debt Repaid | - | -0.2 | -0.13 | -0.2 | -0.19 | -0.31 | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.1 | -0.13 | -0.19 | -0.19 | 0.11 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.18 | 0.08 | 3.99 | Upgrade
|
| Repurchase of Common Stock | - | -0.13 | - | - | -0.11 | - | Upgrade
|
| Common Dividends Paid | - | -0.67 | - | - | - | -0.3 | Upgrade
|
| Financing Cash Flow | - | -0.89 | -0.13 | -0.01 | -0.23 | 3.8 | Upgrade
|
| Net Cash Flow | - | -0.71 | -0.42 | 0.28 | -0.13 | 3.94 | Upgrade
|
| Free Cash Flow | - | 0.96 | 1.3 | 0.86 | 0.14 | 0.89 | Upgrade
|
| Free Cash Flow Growth | - | -26.22% | 51.99% | 521.51% | -84.53% | 76.23% | Upgrade
|
| Free Cash Flow Margin | - | 28.77% | 36.23% | 18.05% | 3.30% | 25.39% | Upgrade
|
| Free Cash Flow Per Share | - | 0.14 | - | - | - | 0.14 | Upgrade
|
| Cash Income Tax Paid | - | 0.59 | 0.38 | 0.16 | 0.09 | 0.08 | Upgrade
|
| Levered Free Cash Flow | - | 0.5 | 1.27 | 0.43 | -0.26 | -0.01 | Upgrade
|
| Unlevered Free Cash Flow | - | 0.5 | 1.27 | 0.44 | -0.25 | -0 | Upgrade
|
| Change in Net Working Capital | 0.72 | 0.61 | 0.16 | 0.22 | 1.02 | -0.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.